Literature DB >> 30676179

Epidemiological studies of atomic bomb radiation at the Radiation Effects Research Foundation.

Kotaro Ozasa1, Harry M Cullings2, Waka Ohishi3, Ayumi Hida4, Eric J Grant5.   

Abstract

Epidemiological studies of people who were exposed to atomic bomb radiation and their children who were conceived after parental exposure to radiation (F1) have investigated late health effects of atomic bomb radiation and its transgenerational effects. Those studies were initiated by the Atomic Bomb Casualty Commission (ABCC) in the 1950s. ABCC was reorganized to the Radiation Effects Research Foundation (RERF) in 1975, which continued the work of the ABCC. Follow-up of vital status and cause of death is performed for all RERF cohorts, including the atomic bomb survivors (the Life Span Study: LSS), in utero survivors, and the children of the survivors (F1). Cancer incidence is investigated for accessible subpopulations of the cohorts. Health examinations for subcohorts of the LSS and in utero survivors are conducted as the Adult Health Study (AHS); a program of health examinations for a subcohort of the F1 study is called the F1 Offspring Clinical Study (FOCS). Participants of all clinical programs are asked to donate their blood and urine for storage and future biomedical investigations. Epidemiological studies have observed increased radiation risks for malignant diseases among survivors including those exposed in utero, and possible risks for some noncancer diseases. No increased risks due to parental exposure to radiation have been observed for malignancies or other diseases in F1, but continuing investigations are required.

Entities:  

Keywords:  Atomic bomb; cancer; dosimetry; genetic effects; noncancer disease

Mesh:

Year:  2019        PMID: 30676179     DOI: 10.1080/09553002.2019.1569778

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  17 in total

1.  Radiation risk of central nervous system tumors in the Life Span Study of atomic bomb survivors, 1958-2009.

Authors:  Alina V Brenner; Hiromi Sugiyama; Dale L Preston; Ritsu Sakata; Benjamin French; Atsuko Sadakane; Elizabeth K Cahoon; Mai Utada; Kiyohiko Mabuchi; Kotaro Ozasa
Journal:  Eur J Epidemiol       Date:  2020-01-25       Impact factor: 8.082

2.  Misclassification of primary liver cancer in the Life Span Study of atomic bomb survivors.

Authors:  Benjamin French; Atsuko Sadakane; John Cologne; Kiyohiko Mabuchi; Kotaro Ozasa; Dale L Preston
Journal:  Int J Cancer       Date:  2020-02-15       Impact factor: 7.396

3.  Comparative metabolic profiles of total and partial body radiation exposure in mice using an untargeted metabolomics approach.

Authors:  Kiran Maan; Ritu Tyagi; Ajaswrata Dutta; Radhika Bakhshi; Poonam Rana
Journal:  Metabolomics       Date:  2020-11-27       Impact factor: 4.290

4.  Radiation cancer risk at different dose rates: new dose-rate effectiveness factors derived from revised A-bomb radiation dosimetry data and non-tumor doses.

Authors:  Hiroshi Tanooka
Journal:  J Radiat Res       Date:  2022-01-20       Impact factor: 2.724

5.  Total-Body Irradiation Is Associated With Increased Incidence of Mesenchymal Neoplasia in a Radiation Late Effects Cohort of Rhesus Macaques (Macaca mulatta).

Authors:  W Shane Sills; Janet A Tooze; John D Olson; David L Caudell; Greg O Dugan; Brendan J Johnson; Nancy D Kock; Rachel N Andrews; George W Schaaf; Richard A Lang; J Mark Cline
Journal:  Int J Radiat Oncol Biol Phys       Date:  2022-03-29       Impact factor: 8.013

6.  Risk of Prostate Cancer Incidence among Atomic Bomb Survivors: 1958-2009.

Authors:  Kiyohiko Mabuchi; Dale L Preston; Alina V Brenner; Hiromi Sugiyama; Mai Utada; Ritsu Sakata; Atsuko Sadakane; Eric J Grant; Benjamin French; Elizabeth K Cahoon; Kotaro Ozasa
Journal:  Radiat Res       Date:  2021-01-01       Impact factor: 2.841

Review 7.  Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

8.  Relationship Between Radiation Exposure and Incident Atrial Fibrillation Among Atomic Bomb Survivors.

Authors:  Daisuke Haruta; Reid D Landes; Ayumi Hida; Misa Imaizumi; Waka Ohishi; Masazumi Akahoshi; Koji Maemura
Journal:  Circ Rep       Date:  2021-06-11

9.  Association of human T-cell leukemia virus type 1 with prevalent rheumatoid arthritis among atomic bomb survivors: A cross-sectional study.

Authors:  Ayumi Hida; Misa Imaizumi; Benjamin French; Waka Ohishi; Daisuke Haruta; Katsumi Eguchi; Hideki Nakamura; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

10.  Analyses of cancer incidence and other morbidities in gamma irradiated B6CF1 mice.

Authors:  Alia Zander; Tatjana Paunesku; Gayle E Woloschak
Journal:  PLoS One       Date:  2020-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.